Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells

L Eiselleova, K Matulka, V Kriz, M Kunova, Z Schmidtova, J Neradil, B Tichy, D Dvorakova, S Pospisilova, A Hampl, P Dvorak

. 2009 ; 27 (8) : 1847-1857.

Jazyk angličtina Země Spojené státy americké

Perzistentní odkaz   https://www.medvik.cz/link/bmc12009163

The transcription program that is responsible for the pluripotency of human ESCs (hESCs) is believed to be comaintained by exogenous fibroblast growth factor-2 (FGF-2), which activates FGF receptors (FGFRs) and stimulates the mitogen-activated protein kinase (MAPK) pathway. However, the same pathway is stimulated by insulin receptors, insulin-like growth factor 1 receptors, and epidermal growth factor receptors. This mechanism is further complicated by intracrine FGF signals. Thus, the molecular mechanisms by which FGF-2 promotes the undifferentiated growth of hESCs are unclear. Here we show that, in undifferentiated hESCs, exogenous FGF-2 stimulated the expression of stem cell genes while suppressing cell death and apoptosis genes. Inhibition of autocrine FGF signaling caused upregulation of differentiation-related genes and downregulation of stem cell genes. Thus, exogenous FGF-2 reinforced the pluripotency maintenance program of intracrine FGF-2 signaling. Consistent with this hypothesis, expression of endogenous FGF-2 decreased during hESC differentiation and FGF-2 knockdown-induced hESC differentiation. In addition, FGF-2 signaling via FGFR2 activated MAPK kinase/extracellular signal-regulated kinase and AKT kinases, protected hESC from stress-induced cell death, and increased hESC adhesion and cloning efficiency. This stimulation of self-renewal, cell survival, and adhesion by exogenous and endogenous FGF-2 may synergize to maintain the undifferentiated growth of hESCs.

Citace poskytuje Crossref.org

000      
03972naa a2200637 a 4500
001      
bmc12009163
003      
CZ-PrNML
005      
20240109133120.0
008      
120319s2009 xxu eng||
009      
AR
024    __
$a 10.1002/stem.128 $2 doi
035    __
$a (PubMed)19544431
040    __
$d ABA008 $a ABA008 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Eiselleová, Lívia $7 _AN059522 $u Department of Biology, Faculty of Medicine University Hospital Brno and Faculty of Medicine, Masaryk University, Brno
245    12
$a A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells / $c L Eiselleova, K Matulka, V Kriz, M Kunova, Z Schmidtova, J Neradil, B Tichy, D Dvorakova, S Pospisilova, A Hampl, P Dvorak
520    9_
$a The transcription program that is responsible for the pluripotency of human ESCs (hESCs) is believed to be comaintained by exogenous fibroblast growth factor-2 (FGF-2), which activates FGF receptors (FGFRs) and stimulates the mitogen-activated protein kinase (MAPK) pathway. However, the same pathway is stimulated by insulin receptors, insulin-like growth factor 1 receptors, and epidermal growth factor receptors. This mechanism is further complicated by intracrine FGF signals. Thus, the molecular mechanisms by which FGF-2 promotes the undifferentiated growth of hESCs are unclear. Here we show that, in undifferentiated hESCs, exogenous FGF-2 stimulated the expression of stem cell genes while suppressing cell death and apoptosis genes. Inhibition of autocrine FGF signaling caused upregulation of differentiation-related genes and downregulation of stem cell genes. Thus, exogenous FGF-2 reinforced the pluripotency maintenance program of intracrine FGF-2 signaling. Consistent with this hypothesis, expression of endogenous FGF-2 decreased during hESC differentiation and FGF-2 knockdown-induced hESC differentiation. In addition, FGF-2 signaling via FGFR2 activated MAPK kinase/extracellular signal-regulated kinase and AKT kinases, protected hESC from stress-induced cell death, and increased hESC adhesion and cloning efficiency. This stimulation of self-renewal, cell survival, and adhesion by exogenous and endogenous FGF-2 may synergize to maintain the undifferentiated growth of hESCs.
590    __
$a bohemika - dle Pubmed
650    02
$a Cell Adhesion $x de [Drug Effects]
650    02
$a Cell Adhesion $x ph [Physiology]
650    02
$a Cell Differentiation $x de [Drug Effects]
650    02
$a Cell Differentiation $x ph [Physiology]
650    02
$a Cell Growth Processes $x de [Drug Effects]
650    02
$a Cell Growth Processes $x ph [Physiology]
650    02
$a Cell Line
650    02
$a Cell Survival $x de [Drug Effects]
650    02
$a Cell Survival $x ph [Physiology]
650    02
$a Down-Regulation
650    02
$a Embryonic Stem Cells $x cy [Cytology]
650    02
$a Embryonic Stem Cells $x de [Drug Effects]
650    02
$a Embryonic Stem Cells $x me [Metabolism]
650    02
$a Enzyme Activation
650    02
$a Fibroblast Growth Factor 2 $x ge [Genetics]
650    02
$a Fibroblast Growth Factor 2 $x me [Metabolism]
650    02
$a Fibroblast Growth Factor 2 $x pd [Pharmacology]
650    02
$a Gene Expression
650    _2
$a lidé $7 D006801
650    02
$a Immunoblotting
650    02
$a Mitogen-Activated Protein Kinases $x me [Metabolism]
650    02
$a Oncogene Protein v-akt $x me [Metabolism]
650    02
$a Phosphorylation
650    02
$a Receptor, Fibroblast Growth Factor, Type 2 $x me [Metabolism]
650    02
$a Reverse Transcriptase Polymerase Chain Reaction
650    02
$a Signal Transduction
700    1_
$a Matulka, Kamil
700    1_
$a Kříž, Vítězslav
700    1_
$a Kunová, Michaela
700    1_
$a Schmidtová, Zuzana
700    1_
$a Neradil, Jakub $7 xx0079539
700    1_
$a Tichý, Boris $7 xx0312236
700    1_
$a Dvořáková, Dana, $d 1957- $7 xx0070713
700    1_
$a Pospíšilová, Šárka, $d 1969- $7 xx0101843
700    1_
$a Hampl, Aleš, $d 1962- $7 ola2002153626
700    1_
$a Dvořák, Petr, $d 1956- $7 ola2002153627
773    0_
$t Stem Cells $p Stem Cells $g Roč. 27, č. 8 (2009), s. 1847-1857 $x def $w MED00004436
773    0_
$p Stem Cells $g 27(8):1847-57, 2009 Aug
910    __
$a ABA008 $b x $y 4 $z 0
990    __
$a 20120319150923 $b ABA008
991    __
$a 20240109133117 $b ABA008
999    __
$a ok $b bmc $g 902386 $s 766069
BAS    __
$a 3
BMC    __
$a 2009 $b 27 $c 8 $d 1847-1857 $i def $m Stem cells $x MED00004436
LZP    __
$a 2012-1Q10/

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace